dc.contributor.author | Alharbi, Wejdan Alhumaidi A. | |
dc.contributor.author | Almadi, Ebtesam Ali S. | |
dc.contributor.author | Alwabisi, Shoog Abdullah O. | |
dc.contributor.author | Albalawi, Nashwa Zead A. | |
dc.contributor.author | Alanazi, Hamdah Hnef S. | |
dc.contributor.author | Althobaiti, Alanoud Abdullah H. | |
dc.contributor.author | Alkhathami, Amirah Ali M. | |
dc.contributor.author | Alamrani, Amani Salem K. | |
dc.contributor.author | Altemani, Omniah Salem D. | |
dc.contributor.author | Mohammedsaleh, Maani Mahmoud A. | |
dc.contributor.author | Aljuhani, Arwa Mohammed Alrefai | |
dc.contributor.author | Alrashidi, Rinad Rasheed M. | |
dc.contributor.author | Ibrahim, Ahmed Abdulaziz G. | |
dc.contributor.author | AlMutairi, Mazyad Hamed M. | |
dc.contributor.author | ALMutairi, Abeer Fahad M. | |
dc.date.accessioned | 2022-02-18T10:39:28Z | |
dc.date.available | 2022-02-18T10:39:28Z | |
dc.date.issued | 2021 | |
dc.identifier.citation | Ibrahim A. A. G. , AlMutairi M. H. M. , ALMutairi A. F. M. , Alharbi W. A. A. , Almadi E. A. S. , Alwabisi S. A. O. , Albalawi N. Z. A. , Alanazi H. H. S. , Althobaiti A. A. H. , Alkhathami A. A. M. , et al., "Updated Treatment of Fibromyalgia Syndrome: A Review", JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL, cilt.33, sa.52B, ss.72-79, 2021 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_b00bf9a2-be34-4ef6-b44e-69cc87e91cd8 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/179642 | |
dc.identifier.uri | https://doi.org/10.9734/jpri/2021/v33i52b33601 | |
dc.description.abstract | Fibromyalgia is a debilitating condition that is frequently misdiagnosed. It affects 2% of the population, with middle-aged women having the highest frequency. Fibromyalgia affects more women than men, and It becomes worse as you get older. Because medical treatment for fibromyalgia is typically only partial, health professionals must provide patients with ongoing assistance in order for them to become effective, active self-managers. There is no one-size-fits-all drug for fibromyalgia, but you do have a lot of options for treating your symptoms. However, Antidepressants in general such as "duloxetine" and Gabapentinoids drugs such as "pregabline" are the most used drugs. There is some evidence that NSAIDs may have a synergistic effect when combined with centrally active agents such as tricyclic antidepressants and anticonvulsants. Among non-pharmacological therapy, exercise and psychoeducational techniques have the most evidence of efficacy, but they must be personalized to the individual. In this review we will be looking at diagnosis and treatment of fibromyalgia. | |
dc.language.iso | eng | |
dc.subject | Pharmacy | |
dc.subject | FARMAKOLOJİ VE ECZACILIK | |
dc.subject | Farmakoloji ve Toksikoloji | |
dc.subject | Yaşam Bilimleri (LIFE) | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Eczacılık | |
dc.subject | Temel Eczacılık Bilimleri | |
dc.subject | Yaşam Bilimleri | |
dc.subject | Temel Bilimler | |
dc.subject | Pharmacology | |
dc.subject | General Pharmacology, Toxicology and Pharmaceutics | |
dc.subject | Pharmacology, Toxicology and Pharmaceutics (miscellaneous) | |
dc.subject | Pharmacology (medical) | |
dc.subject | Drug Guides | |
dc.subject | Life Sciences | |
dc.subject | Health Sciences | |
dc.title | Updated Treatment of Fibromyalgia Syndrome: A Review | |
dc.type | Makale | |
dc.relation.journal | JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL | |
dc.contributor.department | King Salman Mil Hosp , , | |
dc.identifier.volume | 33 | |
dc.identifier.issue | 52B | |
dc.identifier.startpage | 72 | |
dc.identifier.endpage | 79 | |
dc.contributor.firstauthorID | 2774085 | |